Financial Performance - Revenue for the three months ended September 30, 2023, was $168,569 million, a 26% increase from $133,709 million in the same period of 2022[18]. - Gross profit for the nine months ended September 30, 2023, reached $197,139 million, up from $129,810 million, reflecting a 52% increase year-over-year[18]. - Net income attributable to ACM Research, Inc. for the three months ended September 30, 2023, was $25,679 million, up from $21,004 million in the same period of 2022, representing a 22% increase[18]. - Net income for the nine months ended September 30, 2023, was $73,554 thousand, compared to $36,381 thousand for the same period in 2022, representing a 102% increase[26]. - Basic net income attributable to ACM Research, Inc. per share for the three months ended September 30, 2023, was $0.43, compared to $0.35 in the same period of 2022[18]. - For the three months ended September 30, 2023, net income was $30,994,000, an increase of 14.1% compared to $27,076,000 for the same period in 2022[93]. - For the nine months ended September 30, 2023, total revenue reached $387,402,000, compared to $280,290,000 for the same period in 2022, indicating a growth of 38.2%[102]. Assets and Liabilities - Total current assets increased to $1,115,894 thousand as of September 30, 2023, compared to $963,806 thousand at December 31, 2022, representing a growth of approximately 15.8%[15]. - Total liabilities grew to $532,118 thousand from $423,329 thousand, an increase of approximately 25.7%[15]. - Stockholders' equity increased to $729,050 thousand from $674,856 thousand, representing a growth of about 8%[15]. - Total equity as of September 30, 2023, was $878,130 thousand, up from $774,098 thousand as of June 30, 2023, indicating a growth of approximately 13.4%[23]. - Property, plant, and equipment net value rose to $190.9 million as of September 30, 2023, from $82.9 million as of December 31, 2022[119]. - Long-term borrowings rose to $39,753 thousand from $18,687 thousand, an increase of approximately 112.5%[15]. Cash Flow and Investments - Cash flow used in operating activities for the nine months ended September 30, 2023, was $(42,117) thousand, an improvement from $(61,397) thousand in the same period of 2022[26]. - Cash, cash equivalents, and restricted cash at the end of the period were $207,661 thousand, down from $336,642 thousand at the end of the previous period[27]. - The company reported a net decrease in cash of $(40,790) thousand for the nine months ended September 30, 2023, compared to $(226,425) thousand for the same period in 2022[27]. - The company has significant time deposits totaling $118,834 as of September 30, 2023, down from $172,448 on December 31, 2022, a decrease of 31.1%[80]. - The company incurred a total of $7,952 in purchases from related party Ninebell for the three months ended September 30, 2023, down from $12,132 in the same period of 2022, representing a decrease of 34.9%[164]. Operating Expenses - Operating expenses for the three months ended September 30, 2023, totaled $55,341 million, compared to $34,331 million in the same period of 2022, marking a 61% increase[18]. - The total operating expenses for the nine months ended September 30, 2023, were $124,674 million, compared to $87,445 million in the same period of 2022, reflecting a 43% increase[18]. - Research and development expenses for the three months ended September 30, 2023, were $26,151 million, a significant increase from $15,678 million in the same period of 2022, reflecting a 67% rise[18]. Regulatory and Market Risks - The company is facing regulatory risks due to new export controls from Japan and the Netherlands, which may adversely impact shipments and sales in mainland China[59]. - ACM Shanghai's customers and operations are primarily based in mainland China, which poses risks due to recent U.S. export restrictions affecting semiconductor manufacturing[53]. - The U.S. government enacted new rules in October 2022 and revised them in October 2023, impacting ACM's ability to support customers in mainland China[53]. Stock and Equity - ACM issued 623,244 shares of Class A common stock during the three months ended September 30, 2023, compared to 231,710 shares issued in the same period of 2022, reflecting a 169.5% increase[166]. - The number of shares of Class A common stock issued and outstanding increased to 55,574,734 as of September 30, 2023, from 54,655,286 as of December 31, 2022[166]. - The total stock-based compensation expense for the nine months ended September 30, 2023, was $14,666 thousand, compared to $5,236 thousand for the same period in 2022, representing an increase of 180%[187]. Taxation - The company recorded an income tax expense of $11,235 thousand for the nine months ended September 30, 2023, down from $14,138 thousand in the same period of 2022[193]. - The effective income tax rate for ACM differs from statutory rates due to valuation allowances and permanent differences, impacting the overall tax expense recorded[193]. - The Company has total unrecognized tax benefits of $8,448, with a potential net impact of $6,178 on the effective tax rate if recognized[195].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-38273 ACM Research, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 94-3290283 (Sta ...

ACM Research, Inc. (NASDAQ:ACMR) Q2 2023 Earnings Conference Call August 4, 2023 8:00 AM ET Company Participants Yujia Zhai - Investor Relations, The Blueshirt Group David Wang - Chief Executive Officer Mark McKechnie - Chief Financial Officer Conference Call Participants Quinn Bolton - Needham & Company Suji Desilva - ROTH Capital Christian Schwab - Craig-Hallum Capital Chaolien Tseng - Credit Suisse Mark Miller - The Benchmark Company Robert McKay - Blue Lotus Operator Good morning, and thank you for stan ...

Supplemental Investor Presentation Earnings Release – Second Quarter 2023 Forward-Looking Statements.Certain statements contained in this presentation are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words areintended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-38273 ACM Research, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 94-3290283 (St ...

ACM Research, Inc. (NASDAQ:ACMR) Q1 2023 Results Conference Call May 5, 2023 8:00 AM ET Company Participants Gary Dvorchak - Managing Director, Blueshirt Group David Wang - CEO Mark McKechnie - CFO Conference Call Participants Quinn Bolton - Needham & Company Suji Desilva - Roth Capital Charlie Chan - Morgan Stanley Christian Schwab - Craig-Hallum Donnie Teng - Nomura Mark Miller - Benchmark Operator Thank you for standing by, and welcome to the ACM Research First Quarter 2023 Earnings Conference Call. At t ...

Revenue and Market Performance - Revenue from wet cleaning and other front-end processing tools totaled $308.5 million, accounting for 79.3% of total revenue in 2022, up from $202.3 million (77.9%) in 2021[8]. - Revenue from advanced packaging and other processing tools reached $80.3 million, representing 20.7% of total revenue in 2022, compared to $57.5 million (22.1%) in 2021[8]. - The total available global market for wafer fab equipment increased by 7.6% from $20.1 billion in 2021 to $21.6 billion in 2022, but is expected to decrease by 19.6% to $17.4 billion in 2023[8]. - The worldwide semiconductor wafer fab equipment market grew by 8.9% from $92.4 billion in 2021 to $100.5 billion in 2022, with an anticipated decrease of 19.0% to $81.5 billion in 2023[8]. - In 2022, 43.8% of the company's revenue was derived from three customers, with Huali Huahong Group accounting for 18.2%, SMIC for 15.6%, and YMTC for 10.0%[28]. - The company delivered over 380 wet cleaning and front-end processing tools since 2009, with more than 290 being repeat orders[28]. Product Development and Technology - The company introduced two major new product categories in 2022: the Ultra Pmax™ PECVD tool and the Ultra Track tool, enhancing performance across defectivity, throughput, and cost of ownership[9]. - The company’s proprietary SAPS technology has shown to be more effective than conventional methods in removing defects as small as 20nm[12]. - SAPS technology enhances defect removal post-CMP and hard mask deposition, improving wafer surface quality with environmentally friendly chemicals[14]. - SAPS II equipment has a throughput of up to 225 wafers per hour, while SAPS V can process up to 375 wafers per hour, showcasing significant efficiency improvements[17][18]. - TEBO technology enables damage-free cleaning for wafers with features as small as 16nm to 19nm, addressing challenges at process nodes of 28nm and below[19][20]. - TEBO technology can be applied in up to 50 cleaning steps during DRAM chip fabrication, enhancing yield and maintaining chip quality[20]. - Ultra C Tahoe tool reduces sulfuric acid consumption significantly compared to conventional methods, aligning with environmental regulations[25]. - Advanced packaging tools include Ultra C Coater, which automates the coating process and reduces particle generation, improving throughput[27]. - The company focuses on custom-made advanced packaging tools, providing differentiated equipment at competitive prices to meet customer needs[26]. Research and Development - The company's research and development expense totaled $62.2 million, representing 16.0% of revenue in 2022, up from $34.2 million or 13.2% in 2021[33]. - The company aims to develop new cleaning technologies for Ultra C SAPS, TEBO, and Tahoe tools, targeting logic chips, DRAM, and 3D NAND technologies[33]. - The company has been issued more than 448 patents across multiple countries, including the United States and China[9]. - As of December 31, 2022, the company held 41 issued patents and 29 patents pending in the United States, with a total of over 448 patents granted internationally[34]. Operational Expansion - The company is expanding its direct sales and services teams in North America, Western Europe, and Southeast Asia to address customer needs in these regions[9]. - A new 1,000,000 square foot development and production center is under construction in the Lingang region of Shanghai, expected to support increased production capacity and R&D activities[9]. - The manufacturing facilities in Shanghai cover a total of 236,000 square feet, with a new planned facility of 1,000,000 square feet to enhance production capacity[32]. - The company has begun expanding its sales efforts in North America, Western Europe, and Southeast Asia to diversify its customer base[28]. Market Risks and Challenges - The company faces risks related to dependence on a small number of customers for a substantial portion of revenue, which could impact financial stability[52]. - The semiconductor industry is characterized by cyclicality, with analysts forecasting a downturn in global WFE investments in 2023, which could materially affect the company's business[82]. - The company faces substantial competition from larger, well-established competitors with greater financial and operational resources, which may impact market share and growth[89]. - The company may incur significant research and development costs for products that may not be purchased, affecting future cash flow and profitability[93]. - The company is highly dependent on its CEO and senior management, and the loss of key personnel could significantly disrupt operations[110]. Regulatory and Compliance Issues - The company is subject to regulatory risks that could limit its ability to operate effectively in the PRC, including potential changes in government trade policies[55]. - The company has not experienced significant intervention from PRC authorities, but future changes in laws could adversely affect operations[63]. - The company is subject to complex PRC laws and regulations that can change quickly, potentially impacting business operations and financial condition[60]. - The STAR Listing and related regulations could impose new restrictions on ACM Shanghai's operations, affecting its financial condition and stock value[60]. - The company is subject to increased legal, accounting, and compliance costs due to public company regulations, which may adversely affect its financial condition[152]. Impact of COVID-19 - The COVID-19 pandemic has impacted operations, with a significant number of employees infected in late 2022 and early 2023, causing administrative and operational challenges[45]. - The company has implemented safety protocols and provided personal protective equipment to ensure employee health during the pandemic[44]. - The ongoing pandemic may negatively impact planned projects and investments in the PRC, with uncertainty regarding future developments[144]. - The COVID-19 pandemic has adversely affected business operations, with ongoing restrictions in the PRC impacting product development and manufacturing[142]. Financial Performance and Stock Information - The company has never declared or paid cash dividends, intending to retain future earnings for business operations and expansion[148]. - The market price of Class A common stock has been volatile, influenced by factors such as revenue fluctuations and analyst coverage[146]. - The company is listed on the SEC's "Conclusive list of issuers identified under the HFCAA," which could lead to a significant decline in the value of its securities if it remains on the list for two consecutive years[71]. - The company has identified material weaknesses in internal controls over financial reporting, which could impact investor confidence and stock price[58].

ACM Research, Inc. (NASDAQ:ACMR) Q4 2022 Earnings Conference Call February 24, 2023 8:00 AM ET Company Participants Gary Dvorchak - Managing Director, Blueshirt Group David Wang - CEO Mark McKechnie - CFO Conference Call Participants Mark Miller - The Benchmark Company Quinn Bolton - Needham and Company Christian Schwab - Craig-Hallum Capital Group Chaolien Tseng - Credit Suisse Suji Desilva - ROTH Capital Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the ACM Research Fo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-38273 ACM Research, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 94-3290283 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-38273 ACM Research, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 94-3290283 (Sta ...